(S (NP (NN Hypertension)) (VP (VBZ is) (NP (NP (DT a) (JJ medical) (NN condition)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ well-established) (PP (IN as) (NP (NP (DT a) (NN risk) (NN factor)) (PP (IN for) (NP (JJ many) (JJ major) (NNS diseases))))))))))) (. .))
(S (PP (IN For) (NP (NN example))) (, ,) (NP (PRP it)) (VP (MD can) (VP (VB cause) (NP (NP (NNS alterations)) (PP (IN in) (NP (DT the) (JJ cardiac) (NN structure) (CC and) (NN function))) (PP (IN over) (NP (NN time))) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB lead) (PP (TO to) (NP (ADJP (NN heart) (VBN related)) (NN morbidity) (CC and) (NN mortality)))))))))) (. .))
(S (ADVP (RB However)) (, ,) (PP (IN at) (NP (DT the) (JJ subclinical) (NN stage))) (, ,) (NP (DT these) (NNS changes)) (VP (VP (VBP are) (ADJP (JJ subtle))) (CC and) (VP (MD can) (RB not) (VP (VB be) (VP (ADVP (RB easily)) (VBN captured) (S (VP (VBG using) (NP (NP (JJ conventional) (JJ cardiovascular) (NNS indices)) (VP (VBN calculated) (PP (IN from) (NP (JJ clinical) (JJ cardiac) (NN imaging))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP describe) (NP (NP (DT a) (NNS radiomics) (NN approach)) (PP (IN for) (S (VP (VBG identifying) (NP (NP (JJ intermediate) (NN imaging) (NNS phenotypes)) (VP (VBN associated) (PP (IN with) (NP (NN hypertension)))))))))) (. .))
(S (NP (DT The) (NN method)) (VP (VBZ combines) (NP (NP (JJ feature) (NN selection)) (CC and) (NP (NN machine) (VBG learning) (NNS techniques))) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (ADJP (ADJP (RBS most) (JJ subtle)) (CONJP (RB as) (RB well) (IN as)) (JJ complex)) (JJ structural) (CC and) (NN tissue) (NNS changes)) (PP (IN in) (NP (JJ hypertensive) (NNS subgroups))) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (JJ healthy) (NNS individuals))))))))))) (. .))
(S (NP (NP (NNP Validation)) (PP (VBN based) (PP (IN on) (NP (NP (DT a) (NN sample)) (PP (IN of) (NP (JJ asymptomatic) (NNS hearts))) (SBAR (WHNP (WDT that)) (S (VP (VBP include) (NP (UCP (DT both) (JJ hypertensive) (CC and) (JJ non-hypertensive)) (NNS cases))))))))) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (DT the) (VBN proposed) (NNS radiomics) (NN model)) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG detecting) (NP (NN intensity) (CC and) (JJ textural) (NNS changes)) (PP (ADVP (RB well)) (IN beyond) (NP (NP (DT the) (NNS capabilities)) (PP (IN of) (NP (JJ conventional) (NN imaging) (NNS phenotypes)))))))))))) (, ,) (S (VP (VBG indicating) (NP (NP (PRP$ its) (NN potential)) (PP (IN for) (NP (NP (JJ improved) (NN understanding)) (PP (IN of) (NP (NP (DT the) (JJ longitudinal) (NNS effects)) (PP (IN of) (NP (NN hypertension))) (PP (IN on) (NP (JJ cardiovascular) (NN health) (CC and) (NN disease))))))))))) (. .))
